RIPE Knowledge Graph
RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1159%2F000438465

https://w3id.org/ripe/ripe-kg/work/10.1159%2F000438465
SubjectPredicateObject
ripekg:peer-comment/RIPEA01514B7E95B5311F-1 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:peer-comment/RIPEA74BC134B1444B1E9-1 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:peer-comment/RIPEAE6C99CEB4A528D11-1 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:publication-details/RIPEA01514B7E95B5311FChromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:publication-details/RIPEA74BC134B1444B1E9Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:registry-evidence/RIPEA01514B7E95B5311F ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:registry-evidence/RIPEA74BC134B1444B1E9 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:registry-evidence/RIPEAE6C99CEB4A528D11 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:research-integrity-assessment/RIPEA01514B7E95B5311F ripe:assesses ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:research-integrity-assessment/RIPEA74BC134B1444B1E9 ripe:assesses ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:research-integrity-assessment/RIPEAE6C99CEB4A528D11 ripe:assesses ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:study-design-evidence/RIPEA01514B7E95B5311F ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:study-design-evidence/RIPEA74BC134B1444B1E9 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 ripe:concerns ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial prism:doi 10.1159/000438465
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial dcterms:creator ripekg:author/RIPEAU2800E4CE5C23C69BZatollah Asemi
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial dcterms:creator ripekg:author/RIPEAU42780B0A182786C4Mehri Jamilian
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial dcterms:title Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW04FB6B2B4179BAEDASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW097CA93D1F953DBCAltered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW0A4C3C985AC5303FValidation of a simplified method to assess hirsutism in the Iranian population
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW0EA63CD30908E2E1Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: a doubleblind randomized clinical trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW14EE8C600B427685Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW162AFEE786DBABE6Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW1F1248407C5E60E9Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW2036AA1D935CE4F8Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNFalpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW3609827AE151ECD2Martín-Moreno JM: Low toenail chromium concentration and increased risk of nonfatal myocardial infarction
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW45D36BBC311B1BB4Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes: a meta-analysis review of randomized trials
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW48A04C2C54AD9264Cefalu WT: Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW57D990A81002EDAFPolycystic ovary syndrome and cardiovascular disease: a premature association?
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW5FBDA5383543C18CChromium status and glucose tolerance in Saudi men with and without coronary artery disease
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW6481EE41793519AAOral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW8E0B1F21322E138BThe effects of old, new and emerging medicines on metabolic aberrations in PCOS
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW91AEE9CB3AB262B0Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWA2060E62F49A155FChowdhury S: Role of chromium supplementation in Indians with type 2 diabetes mellitus
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWAB7B6C6B93A5FD3CChromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWB1A987D96509A617Canary JJ: Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWCFA1721B56BF4302Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWCFC595929E592560Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWEE8A02086E5D0368Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: characteristics and predictive capacity
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWF0F0AFF5DFB91436Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWFA2C3C25311AE3E8Chromium therapy for insulin resistance associated with HIVdisease
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEWFF5850DF217F5295Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type node1
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type rdfs:Resource
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type owl:Thing
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type prov:Entity
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial rdf:type ripe:WorkWork
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial owl:sameAs https://semopenalex.org/work/W1507408764